Recently, Sinopharm Group Industry Co., Ltd. (hereinafter referred to as "Sinopharm Industry"), a wholly-owned subsidiary of Shanghai Modern Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company"), has received the "Approval Notice for the Marketing Authorization Application of Chemical Active Pharmaceutical Ingredient (API)" issued and approved by the National Medical Products Administration (NMPA) of the People's Republic of China, which approves the marketing authorization application for the API Nalbuphine Hydrochloride. The relevant information is hereby announced as follows:
I. Basic Information of the Chemical API
Name of Chemical API: Nalbuphine Hydrochloride
Registration Number: Y20230000775
Notice Number: 2024YS01375
Registration Standard Number of Chemical API: YBY76782024
Packaging Specifications: 1kg/bag, 2kg/bag
Manufacturer: Langfang Branch of Sinopharm Group Industry Co., Ltd.
Company Address: Chuangye Road, Langfang Economic and Technological Development Zone
Application Item: Marketing authorization application for domestically produced chemical API
Approval Conclusion: In accordance with the "Drug Administration Law of the People's Republic of China" and relevant regulations, after review, this product meets the relevant requirements for drug registration and is approved for registration.
II. Drug R&D and Market Status
Nalbuphine Hydrochloride is a κ-opioid receptor agonist and μ-opioid receptor antagonist, acting as a potent central analgesic. Its related dosage form product, Nalbuphine Hydrochloride Injection, is mainly used as an adjuvant drug for induction of anesthesia during combined anesthesia, and also for relieving moderate to severe pain.
According to the website of the Center for Drug Evaluation (CDE), other domestic enterprises with a registration status of "A" for Nalbuphine Hydrochloride API currently include Yichang Humanwell Pharmaceutical Co., Ltd., Jiangsu Haici Biopharmaceutical Co., Ltd. of Yangzijiang Pharmaceutical Group, etc. Data from the Pharmaceutical Database Builder (PDB) shows that the global consumption of Nalbuphine API in 2023 was 762.49kg.












